| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $8.2B | $7.5B | $7.1B | $6.8B | $6.6B | $1.7B | $1.7B | $5.7B |
| Cost of Revenue | $2.5B | $2.1B | $1.8B | $1.7B | $1.7B | $1.5B | $1.2B | $1.6B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $2.6B | $2.4B | $2.3B | $2.2B | $2.1B | $0.5B | $0.5B | $2.3B |
| Net Income | $1.6B | $1.5B | $1.6B | $1.3B | $1.6B | $0.3B | $1.3B | $1.5B |
| EPS (Basic) | $5.59 | $5.28 | $5.68 | $4.63 | $5.30 | $1.10 | $1.61 | $4.80 |
| EPS (Diluted) | $5.55 | $5.22 | $5.59 | $4.57 | $5.21 | $1.08 | $1.58 | $4.69 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $8.2B | $6.7B | $6.2B | $5.8B | $6.0B | $5.9B | $5.2B | $4.1B |
| Current Assets | $2.0B | $1.9B | $1.6B | $1.6B | $1.5B | $1.7B | $1.5B | $1.2B |
| Cash & Equivalents | $0.7B | $0.6B | $0.5B | $0.4B | $0.5B | $0.7B | $0.6B | $0.3B |
| Total Liabilities | $15.5B | $14.4B | $14.1B | $14.7B | $14.3B | $13.7B | $13.2B | $12.1B |
| Current Liabilities | $1.5B | $1.3B | $1.3B | $1.7B | $1.4B | $1.7B | $1.5B | $1.3B |
| Stockholders' Equity | — | — | — | — | — | — | — | $-7.9B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $2.0B | $1.7B | $1.6B | $1.4B | $1.7B | $1.3B | $1.3B | — |
| Investing Cash Flow | $-1.0B | $-0.4B | $-0.1B | $-0.2B | $-0.2B | $-0.3B | $-0.1B | — |
| Capital Expenditures | $0.4B | $0.3B | $0.3B | $0.3B | $0.2B | $0.2B | $0.2B | — |
| Financing Cash Flow | $-0.9B | $-1.2B | $-1.4B | $-1.3B | $-1.8B | $-0.7B | $-0.9B | — |